Joseph P. Horrigan, MD
- 4Articles
- 16.2KReads
- 2000–2008Active
- 23Collaborators
About
Joseph P. Horrigan, MD, has published research on major depressive disorder, including clinical trials of gepirone extended-release and comparisons of bupropion extended release with escitalopram focusing on antidepressant efficacy and sexual functioning. His work also addresses neurodevelopmental and child and adolescent psychiatry topics, such as the development of an electronic adolescent version of the Quick Inventory of Depressive Symptomatology and studies on low-dose amphetamine salts for adult attention-deficit/hyperactivity disorder. His publications appeared between 2000 and 2008 in Psychiatrist.com journals.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
